Our tech desk: 25 stories on the rings, sensors, home blood panels, light panels and frontier science people are actually buying — graded against 250 cited human studies, with the failures reported. Gizmodo energy, physician standards.
One particle, one measurement, and a cleaner line to risk than the LDL-C most labs report by default.
The bottom line: ApoB counts atherogenic particles rather than weighing the cholesterol inside them, and when it is modelled alongside LDL-C and triglycerides it is the variable that keeps its association with events. It is also an adjunct rather than a screening test: adding it to an existing risk score barely moves discrimination.
Magellan's evidence scale runs 4 = Strong (multiple consistent human studies), 3 = Mixed (human trials that disagree or support only part of the claim), 2 = Early (small, short or uncontrolled human studies), 1 = Preclinical only (animal or laboratory data with no human efficacy result). It grades the strength of the published evidence behind the claim, not the build quality, value or popularity of any product, and it is not a user rating. Grades are set independently of affiliate commissions.
| Grade | What it means |
|---|---|
| Strong evidence | Multiple human studies, consistent direction of effect. Stories: 3 |
| Mixed evidence | Real human trials that disagree, or that support only part of the claim. Stories: 16 |
| Early evidence | Small, short or uncontrolled human studies; the finding is not yet settled. Stories: 4 |
| Preclinical only | Animal or laboratory results with no human efficacy data behind the claim. Stories: 2 |
Rings, watches, cuffs and continuous monitors — measured against the lab equipment they claim to replace. All 6 wearables & sensors stories →
Consumer sleep trackers are good at telling sleep from wake and mediocre at staging it. The validation studies are unusually blunt about which is which.
Heart-rate variability is genuinely linked to mortality. Your overnight RMSSD is still mostly telling you about last night's alcohol.
The sensors are accurate enough. The interpretation — spikes, variability, 'personalised nutrition' — is where the evidence gets thin.
Wrist-worn atrial-fibrillation screening genuinely finds disease. It also generates a lot of notifications that end in nothing.
The dose-response curves from device-measured cohorts bend early and flatten sooner than the marketing suggests.
Home blood pressure is one of the few numbers that changes outcomes. Which is exactly why the device you use has to be a validated one.
Mail-in blood panels, biological-age tests and the handful of numbers actually worth ordering. All 6 home lab & diagnostics stories →
One particle, one measurement, and a cleaner line to risk than the LDL-C most labs report by default.
It is genetically fixed, it raises risk, nothing on the shelf lowers it meaningfully — and the drugs that do are in phase 3.
Send the same blood twice and a first-generation methylation clock can hand back ages years apart. The fix exists; it isn't universal.
Fingerstick dried blood spots are excellent for some analytes and unreliable for others. The kit box rarely tells you which is which.
Most supplement blood tests tell you a number with nothing to compare it to. This one has an outcome-linked target.
High-sensitivity C-reactive protein is a real risk marker and an unusually twitchy one. Interpretation lives or dies on repeat measurement.
Red light, saunas, cold water, compression and sleep hardware — ranked by the strength of the human trials. All 7 recovery, light & heat stories →
Photobiomodulation has decent randomised evidence for skin and pain, a biphasic dose curve, and a marketing layer far ahead of the biology.
The Finnish cohort numbers are striking. They are also observational, and the people who sauna four times a week differ in other ways.
Cold water immersion reliably makes you feel recovered and can reliably interfere with the adaptation you were training for.
Intermittent pneumatic compression is mostly a comfort device. Blood flow restriction training has a surprisingly deep trial literature.
Both have real randomised literature. Both have effect sizes and sample sizes that should make a four-figure price tag uncomfortable.
Four categories of sleep hardware, four very different evidence bases — and the cheapest one has the strongest case.
A small trial reported longer telomeres and fewer senescent cells after 60 sessions. That is a finding, not a purchase order.
Reprogramming, plasma exchange, senolytics, gene therapy and AI drug discovery — what is in humans and what is still a slide deck. All 6 frontier tech stories →
Turn a cell partway back toward youth and stop before it forgets what it is. Everything hard about this is in the word 'partway'.
Dilute the plasma of an old animal and something improves. Doing it to people is a real trial question with early, small answers.
Dasatinib plus quercetin and fisetin have moved out of mice and into small human studies, with results that are more interesting than triumphant.
Clinics offshore will inject a gene into you today. What comes back is a press release, not a result.
Generative models have produced clinical candidates. Whether they can produce an aging drug is a different and harder question.
Brain-computer interfaces are real and are not for aging. The non-invasive stimulation aisle is where the aging claims live, and it is noisy.
| Story | Beat | Evidence | Verdict |
|---|---|---|---|
| Your Ring Says 47 Minutes of Deep Sleep. The Lab Says Maybe. | Wearables & Sensors | Strong | Consumer sleep trackers are reliably good at telling sleep from wake and unreliable at naming sleep stages, so the deep-sleep minutes are the least trustworthy number they show you. Use… |
| HRV: The Number Every Wearable Shows and Almost Everyone Misreads | Wearables & Sensors | Mixed | Low HRV is a well-replicated marker of mortality risk in populations, but your own overnight number is dominated by age, heart rate, medications and measurement conditions. Compare it only… |
| Continuous Glucose Monitors Went Over-the-Counter. Here's What They Can and Can't Tell You. | Wearables & Sensors | Mixed | The sensors are accurate and the reference ranges for people without diabetes are well described, but the meta-analyses find glucose variability is not clearly linked to most… |
| Your Watch Thinks You Have AFib. Read the Fine Print. | Wearables & Sensors | Mixed | A wrist notification means rhythm irregularity, not a diagnosis; in the two largest studies about a third of those who followed up with an ECG patch actually had atrial fibrillation. Three… |
| The Step Count That Moves Mortality (It Isn't 10,000) | Wearables & Sensors | Strong | The mortality curve for daily steps bends between roughly 5,000 and 7,000 a day, and the steepest gains belong to people currently walking least, around three to four thousand. 10,000 was… |
| Cuffless Blood Pressure Is the Holy Grail of Wearables. It Isn't Here Yet. | Wearables & Sensors | Mixed | Out-of-office blood pressure carries prognostic information that clinic readings do not, but only a minority of home cuffs sold online has ever passed a validation protocol - and cuffless… |
| ApoB: The Cholesterol Number Your Panel Probably Didn't Print | Home Lab & Diagnostics | Strong | ApoB counts atherogenic particles rather than weighing the cholesterol inside them, and when it is modelled alongside LDL-C and triglycerides it is the variable that keeps its association… |
| Lp(a): Test It Once, Then Watch the Drug Pipeline | Home Lab & Diagnostics | Mixed | Lp(a) is a largely genetic, causally implicated cardiovascular risk factor that guidelines say every adult should measure at least once - and that nothing approved currently lowers. Three… |
| Biological Age Tests: The Reliability Problem Nobody Advertises | Home Lab & Diagnostics | Early | First-generation methylation clocks have shown deviations of up to nine years between replicates of the same sample, and retraining them on principal components is the published fix - one… |
| Mail-In Blood Panels: What a Drop of Blood Can and Can't Measure | Home Lab & Diagnostics | Mixed | Whether a mail-in blood test is trustworthy depends on the analyte and the collection format rather than the brand: mass-spectrometry vitamin D from a dried spot agrees well with plasma,… |
| The Omega-3 Index: The Rare Supplement Test With a Target Range | Home Lab & Diagnostics | Mixed | The omega-3 index is one of the few supplement biomarkers with outcome-derived cut-points, and a higher index tracks lower mortality across 17 cohorts. But the largest randomised… |
| hs-CRP: One High Reading Means Retest, Not Panic | Home Lab & Diagnostics | Mixed | hs-CRP predicts cardiovascular and non-cardiovascular events, but within-person variation of about 50 percent means a single reading misclassifies your risk quartile roughly a third of the… |
| Red Light Therapy: The Skin Data Is Real, the Longevity Claims Aren't | Recovery, Light & Heat | Mixed | Randomised trials support red light for wrinkle volume, skin roughness and musculoskeletal pain at specific doses, and the dose-response is biphasic so more is not better. Nothing in this… |
| Sauna and Mortality: A Beautiful Correlation With a Confounding Problem | Recovery, Light & Heat | Mixed | The Finnish cohort's inverse association between frequent sauna use and cardiovascular death is large, consistent and observational, and a fitness analysis in the same men suggests… |
| Cold Plunges Blunt the Gains You Just Earned. Sometimes That's Fine. | Recovery, Light & Heat | Mixed | Cold water immersion reliably reduces soreness and fatigue, and reliably attenuates type II fibre growth when used after strength training. The mood, immune and brown-fat claims are null… |
| Compression Boots and Blood Flow Restriction: One Is Better Studied Than You'd Guess | Recovery, Light & Heat | Mixed | Pneumatic compression reliably changes how sore you feel and reliably fails to change what you can do, with one moderate-certainty meta-analysis finding no soreness benefit at 24 hours at… |
| PEMF Mats and Vibration Plates: Small Trials, Big Prices | Recovery, Light & Heat | Mixed | PEMF mats sold for home use rest on 11 small sham-controlled trials whose authors said the evidence was insufficient, and the osteoarthritis pain literature actively contradicts itself.… |
| Sleep Tech, Ranked by Evidence: Cooling, Weight, Noise, Light | Recovery, Light & Heat | Mixed | The best-evidenced temperature intervention in the sleep literature is a warm bath before bed, and the best-evidenced device is a bright light lamp used to shift circadian timing rather… |
| Hyperbaric Oxygen at Home: One Telomere Study Is Not a Protocol | Recovery, Light & Heat | Early | The telomere finding driving the entire home-hyperbaric market came from a single-arm, uncontrolled trial in 35 adults, measured only in isolated blood cells, with a standard deviation… |
| Partial Reprogramming: The Best Idea in Aging Biology, and Its Cliff Edge | Frontier Tech | Preclinical only | Partial reprogramming has restored vision in mice, extended lifespan in progeroid mice and in very old male mice, and reset epigenetic markers in human cells in a dish - and has never… |
| Plasma Exchange: Young Blood Without the Young Blood | Frontier Tech | Mixed | In mice, diluting old plasma reproduces most of the young-blood effect, which makes plasma exchange a legitimate research question. In humans it has met one co-primary endpoint and missed… |
| Senolytics Finished Real Trials. Here's What They Showed. | Frontier Tech | Early | Senolytics demonstrably clear senescent cells in humans, which is a real result. But the open-label pilots were tiny, the randomized trials with efficacy endpoints have missed them, and… |
| Follistatin, Klotho, Telomerase: Gene Therapy You Can Buy on an Island | Frontier Tech | Preclinical only | Follistatin, klotho and telomerase have real preclinical evidence and essentially no human longevity evidence. What offshore clinics generate is unblinded, uncontrolled, unregistered… |
| AI Found a Fibrosis Drug and Put It in Humans. Aging Is Next on the Slide Deck. | Frontier Tech | Early | A generative-AI molecule has completed a randomized phase 2a in lung fibrosis, which is a genuine first - but its primary endpoint was safety, and no AI-discovered compound has ever been… |
| Neurotech for Aging Brains: Implants, Ultrasound, and a Lot of Electrodes | Frontier Tech | Mixed | Implanted brain-computer interfaces are extraordinary and are being tested in paralysis, not aging. On the aging side, sham-controlled tDCS has a positive pooled effect on episodic memory,… |
The longevity supplement guide · Longevity research map · Pathway universe · Long reads · Study write-ups
Storefront categories covering this hardware: Biometric Wearables & Sensors · Diagnostics & Epigenetic Tests · Recovery, Sauna & Light Therapy · Air, Water & Sleep Systems
Markers the desk keeps returning to: ApoB · Lipoprotein(a) · hs-CRP · Omega-3 · Heart-rate variability · Glucose · Epigenetic clocks · Senescent cells